Department of Health and Social Care written question – answered at on 22 November 2023.
Preet Kaur Gill
Shadow Minister (Primary Care and Public Health)
To ask the Secretary of State for Health and Social Care, what recent estimate he has made of the number of NHS patients who would be eligible to use Wegovy.
Andrew Stephenson
Assistant Whip, Minister of State (Department of Health and Social Care)
Guidance from the National Institute for Health and Care Excellence (NICE) recommends that Wegovy, otherwise known as semaglutide, is used as an option in the National Health Service for weight management in adults that have at least one weight-related comorbidity and a body mass index (BMI) of at least 35.0 kg/m2, or a BMI of 30.0 kg/m2 to 34.9 kg/m2 and meet the criteria for referral to specialist weight management services in NICE’s clinical guideline on obesity: identification, assessment and management, which is available at the following link:
https://www.nice.org.uk/guidance/cg189.
Wegovy is recommended for use within a specialist weight management service providing multidisciplinary management of overweight or obesity (including but not limited to tiers three and four).
The Department estimates that more people will be eligible for this treatment than could be treated if access is only available through specialist weight management services, which are primarily hospital-based services. That is why we have announced up to £40 million funding over two years to explore ways to make obesity drugs safely available to more patients living with obesity outside of hospital settings.
Yes1 person thinks so
No2 people think not
Would you like to ask a question like this yourself? Use our Freedom of Information site.
Secretary of State was originally the title given to the two officials who conducted the Royal Correspondence under Elizabeth I. Now it is the title held by some of the more important Government Ministers, for example the Secretary of State for Foreign Affairs.
